⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
GH
New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response
businesswire.com
GH
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
businesswire.com
GH
Guardant Health Announces Pricing of Upsized Public Offering of Common Stock
businesswire.com
GH
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering
businesswire.com
GH
Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033
businesswire.com
GH
Guardant Health Announces Proposed Public Offering of Common Stock
businesswire.com
GH
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
businesswire.com
GH
Guardant Health and Zephyr AI Announce Partnership to Unlock Drug Response Predictions and Biomarker Insights
businesswire.com
GH
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
businesswire.com
GH